BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 36907990)

  • 1. Salidroside postconditioning attenuates ferroptosis-mediated lung ischemia-reperfusion injury by activating the Nrf2/SLC7A11 signaling axis.
    Wang Y; Chen Z; Luo J; Zhang J; Sang AM; Cheng ZS; Li XY
    Int Immunopharmacol; 2023 Feb; 115():109731. PubMed ID: 36907990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postconditioning with Irisin Attenuates Lung Ischemia/Reperfusion Injury by Suppressing Ferroptosis via Induction of the Nrf2/HO-1 Signal Axis.
    Wang Y; Dong Z; Zhang Z; Wang Y; Yang K; Li X
    Oxid Med Cell Longev; 2022; 2022():9911167. PubMed ID: 35281462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-432-5p Inhibits the Ferroptosis in Cardiomyocytes Induced by Hypoxia/Reoxygenation via Activating Nrf2/SLC7A11 Axis by Degrading Keap1.
    Geng W; Yan S; Li X; Liu Q; Zhang X; Gu X; Tian X; Jiang Y
    Anal Cell Pathol (Amst); 2023; 2023():1293200. PubMed ID: 37822721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ozone-mediated cerebral protection: Unraveling the mechanism through ferroptosis and the NRF2/SLC7A11/GPX4 signaling pathway.
    Zhu F; Ding S; Liu Y; Wang X; Wu Z
    J Chem Neuroanat; 2024 Mar; 136():102387. PubMed ID: 38182039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia/reperfusion-induced acute lung injury.
    Li Y; Cao Y; Xiao J; Shang J; Tan Q; Ping F; Huang W; Wu F; Zhang H; Zhang X
    Cell Death Differ; 2020 Sep; 27(9):2635-2650. PubMed ID: 32203170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NLRP3 inflammasome deficiency attenuates cerebral ischemia-reperfusion injury by inhibiting ferroptosis.
    Wang Z; Li Y; Ye Y; Zhu H; Zhang J; Wang H; Lei J; Gu L; Zhan L
    Brain Res Bull; 2023 Feb; 193():37-46. PubMed ID: 36435361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propofol Inhibits Ferroptotic Cell Death Through the Nrf2/Gpx4 Signaling Pathway in the Mouse Model of Cerebral Ischemia-Reperfusion Injury.
    Fan GB; Li Y; Xu GS; Zhao AY; Jin HJ; Sun SQ; Qi SH
    Neurochem Res; 2023 Mar; 48(3):956-966. PubMed ID: 36402927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of MALT1 reduces ferroptosis in rat hearts following ischemia/reperfusion via enhancing the Nrf2/SLC7A11 pathway.
    Jiang YQ; Yang XY; Duan DQ; Zhang YY; Li NS; Tang LJ; Peng J; Luo XJ
    Eur J Pharmacol; 2023 Jul; 950():175774. PubMed ID: 37146710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimethyl fumarate protects against hepatic ischemia-reperfusion injury by alleviating ferroptosis via the NRF2/SLC7A11/HO-1 axis.
    Qi D; Chen P; Bao H; Zhang L; Sun K; Song S; Li T
    Cell Cycle; 2023 Apr; 22(7):818-828. PubMed ID: 36482709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salidroside alleviates cognitive impairment by inhibiting ferroptosis via activation of the Nrf2/GPX4 axis in SAMP8 mice.
    Yang S; Wang L; Zeng Y; Wang Y; Pei T; Xie Z; Xiong Q; Wei H; Li W; Li J; Su Q; Wei D; Cheng W
    Phytomedicine; 2023 Jun; 114():154762. PubMed ID: 36965372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitexin attenuates chronic kidney disease by inhibiting renal tubular epithelial cell ferroptosis via NRF2 activation.
    Song J; Wang H; Sheng J; Zhang W; Lei J; Gan W; Cai F; Yang Y
    Mol Med; 2023 Oct; 29(1):147. PubMed ID: 37891461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrf2 attenuates ferroptosis-mediated IIR-ALI by modulating TERT and SLC7A11.
    Dong H; Xia Y; Jin S; Xue C; Wang Y; Hu R; Jiang H
    Cell Death Dis; 2021 Oct; 12(11):1027. PubMed ID: 34716298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway.
    Yang T; Liu H; Yang C; Mo H; Wang X; Song X; Jiang L; Deng P; Chen R; Wu P; Chen A; Yan J
    Drug Des Devel Ther; 2023; 17():2495-2511. PubMed ID: 37637264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salidroside Mediated the Nrf2/GPX4 Pathway to Attenuates Ferroptosis in Parkinson's Disease.
    Shen J; Chen S; Li X; Wu L; Mao X; Jiang J; Zhu D
    Neurochem Res; 2024 May; 49(5):1291-1305. PubMed ID: 38424396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentoxifylline protects against cerebral ischaemia-reperfusion injury through ferroptosis regulation via the Nrf2/SLC7A11/GPX4 signalling pathway.
    Li P; Chen JM; Ge SH; Sun ML; Lu JD; Liu F; Wang LL; Zhang X; Wang XP
    Eur J Pharmacol; 2024 Mar; 967():176402. PubMed ID: 38331339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoliquiritigenin alleviates myocardial ischemia-reperfusion injury by regulating the Nrf2/HO-1/SLC7a11/GPX4 axis in mice.
    Yao D; Bao L; Wang S; Tan M; Xu Y; Wu T; Zhang Z; Gong K
    Free Radic Biol Med; 2024 May; 221():1-12. PubMed ID: 38734270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to "Salidroside postconditioning attenuates ferroptosis-mediated lung ischemia-reperfusion injury by activating the Nrf2/SLC7A11 signaling axis" [Int. Immunopharmacol. 115 (2023) 109731].
    Wang Y; Chen Z; Luo J; Zhang J; Sang AM; Cheng ZS; Li XY
    Int Immunopharmacol; 2023 Apr; 117():110002. PubMed ID: 36925352
    [No Abstract]   [Full Text] [Related]  

  • 18. Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis.
    Wang Z; Yao M; Jiang L; Wang L; Yang Y; Wang Q; Qian X; Zhao Y; Qian J
    Biomed Pharmacother; 2022 Oct; 154():113572. PubMed ID: 35988428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaempferol Ameliorates Oxygen-Glucose Deprivation/Reoxygenation-Induced Neuronal Ferroptosis by Activating Nrf2/SLC7A11/GPX4 Axis.
    Yuan Y; Zhai Y; Chen J; Xu X; Wang H
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34206421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6022 attenuates cerebral ischemia/reperfusion injury-induced microglia ferroptosis by promoting Nrf2 nuclear translocation and inhibiting the GSNOR/GSTP1 axis.
    Duan WL; Ma YP; Wang XJ; Ma CS; Han B; Sheng ZM; Dong H; Zhang LY; Li PA; Zhang BG; He MT
    Eur J Pharmacol; 2024 Jun; 972():176553. PubMed ID: 38574838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.